The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.

The field of medical diagnostics and clinical practice is being transformed by the rapid advancement of deep learning ...

The global In Vitro Diagnostics Market is projected to be valued at USD 108.3 billion in 2024 and reach USD 150.13 billion by ...

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics ...

The increasing demand for advanced medical technologies and ongoing innovations has intensified the requirement for specialized regulatory expertise. VANCOUVER, BRITISH COLUMBIA, CANADA, May 13, 2025 ...

A Rutgers Health review of 151 studies finds that minimizing unexplained symptoms sparks shame, trauma and avoidance of care.